$1.99
-0.0803-3.88%
Last update: Jun 2, 11:29 AM
Lexicon Pharmaceuticals Inc Earnings Estimates
LXRXNASDAQ
Lexicon Pharmaceuticals Earnings Estimates, EPS & Revenue | NASDAQ:LXRX
Lexicon Pharmaceuticals (LXRX) is scheduled to report Q2 earnings on August 5, 2026. Analysts estimate EPS of $-0.05 and quarterly revenue of $4.34M.
In the most recent quarter (Q1), Lexicon Pharmaceuticals reported EPS of $0.00, beating estimates of $-0.04 by 1.00%. Revenue came in at $1.09M, missing the estimate of $9.57M by 0.89%.
Lexicon Pharmaceuticals has beaten EPS estimates in 6 consecutive quarters.
Over the last 4 quarters, Lexicon Pharmaceuticals has averaged an EPS surprise of 0.75% and a revenue surprise of 1.84%.
Earnings Date
Aug 5
EPS Estimate
$-0.050
Quarterly Revenue Estimate
$4.34M
Annual Revenue
(as of Mar 31)
(as of Mar 31)
$69.64M
Lexicon Pharmaceuticals Earnings History
Analyze the earnings history of Lexicon Pharmaceuticals using advanced sorting and filters.
Loading calendar...
Lexicon Pharmaceuticals (LXRX) Earnings Per Share
The chart below shows Lexicon Pharmaceuticals's reported EPS compared to analyst estimates over recent quarters.
Lexicon Pharmaceuticals (LXRX) Revenue
The chart below shows Lexicon Pharmaceuticals's reported revenue compared to analyst estimates over recent quarters.
FAQ
When is Lexicon Pharmaceuticals (NASDAQ:LXRX) reporting earnings?
Lexicon Pharmaceuticals (LXRX) is scheduled to report earnings on August 5, 2026. The last reported earnings were for reported on May 7, 2026 for Q1.
What were the latest earnings per share (EPS) for Lexicon Pharmaceuticals (NASDAQ:LXRX)?
The Actual EPS was $0.00, which beat the estimate of $-0.04.
What were Lexicon Pharmaceuticals’s (NASDAQ:LXRX) revenues?
The Actual Revenue was $1.09M, which missed the estimate of $9.57M.
